| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/30/2006 | US20060067885 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell |
| 03/30/2006 | US20060067881 Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products |
| 03/30/2006 | US20060067879 Diagnosis of diseases associated with COX-2 expression |
| 03/30/2006 | CA2580644A1 Imaging reporters of transgene expression |
| 03/30/2006 | CA2579801A1 Metalloproteinase inhibitor imaging agents |
| 03/29/2006 | EP1640022A1 Menthol-containing preparation |
| 03/29/2006 | EP1638612A2 Cox-2-targeted imaging agents |
| 03/29/2006 | EP1638605A2 Delivery of therapeutic compounds to the brain and other tissues |
| 03/29/2006 | EP1638514A2 Use of epha4 and modulator or epha4 for diagnosis, treatment and prevention of cancer |
| 03/29/2006 | EP1638504A1 Non-invasive intravascular thrombolyisis using modified ultrasound techniques |
| 03/29/2006 | EP1638460A1 Directing cells to target tissues or organs |
| 03/29/2006 | EP1411971B1 Use of long pentraxin ptx3 for treating female infertility |
| 03/29/2006 | EP1408118B1 Enzymatic method of producing 4-0-b-d galactopyranosyl-d-xylose, 4-0-b-d-galactopyranosyl-d-xylose obtained using said method, compositions containing same and the use thereof in evaluating intestinal lactase |
| 03/29/2006 | CN1753878A Trimeric macrocyclic substituted benzene derivatives |
| 03/29/2006 | CN1753724A Peptide mediated synthesis of metallic and magnetic materials |
| 03/29/2006 | CN1751742A Traumatism-free type method for establishing animal model of limb deep vein thrombogenesis |
| 03/28/2006 | US7019132 Porphyrin derivatives |
| 03/28/2006 | US7018617 Methods and compositions associated with nociceptive pain |
| 03/28/2006 | US7018616 detection of serum antibodies to tuberculosis using fluorescent dyes conjugated to antigens, then evaluation using analyzing apparatus; biossays |
| 03/28/2006 | US7018615 Administering library then collecting and analyzing sample of biological target material |
| 03/28/2006 | US7018611 Vitronectin receptor antagonist pharmaceuticals |
| 03/28/2006 | US7018365 Threaded syringe with quick stop |
| 03/23/2006 | WO2005099774A3 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 03/23/2006 | US20060062789 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
| 03/23/2006 | US20060062734 Methods and systems for preventing diversion of prescription drugs |
| 03/23/2006 | US20060062733 Medicament/dosimeter combination packaging |
| 03/23/2006 | US20060062732 Medicine for detecting lipid components in vivo and vascular endoscope |
| 03/23/2006 | US20060062731 Dual gradient echo pulse sequence using interleaved spiral-out spiral-in k-space trajectories |
| 03/23/2006 | US20060062730 Increasing transdermal absorption by mixing isostearyl alcohol with a substance such as hair growing agent, a gray-hair prevention agent, a hair-removing agent, a hair-dyeing agent, or a hair-bleaching agent; pantothenyl ethyl ether, minoxidil, or beta-glycyrrhetinic acid |
| 03/23/2006 | US20060062729 Enhanced ligand binding to neurotensin receptors |
| 03/23/2006 | US20060062726 with iodophenyl group (radioisotope), as a membrane component of liposomes, which enables lesion-selective contrast X-ray radiography of a vascular disease; metabolized in the liver, not accumulated in living bodies |
| 03/22/2006 | EP1637128A2 Use of simple amino acids to form porous particles |
| 03/22/2006 | EP1635879A2 Lectin conjugates |
| 03/22/2006 | EP1635878A2 Peptide conjugate for magnetic resonance imaging |
| 03/22/2006 | EP1635877A2 Specific high-relaxivity conjugate compounds for magnetic resonance imaging |
| 03/22/2006 | EP1635876A2 Improved intra-dermal delivery of biologically active agents |
| 03/22/2006 | EP1635869A1 Cancerous disease modifying antibodies |
| 03/22/2006 | EP1635709A1 Blood flow estimates through replenishment curve fitting in ultrasound contrast imaging |
| 03/22/2006 | CN1748791A Haemorrhagic E, coli 0157:H7 vaccine for human and livestock prevention and preparing method |
| 03/22/2006 | CA2581356A1 Histone deacetylase whole cell enzyme assay |
| 03/21/2006 | US7015371 Adjustment, compression of nervous systems; detection, monitoring variations in pain |
| 03/21/2006 | US7014998 Qualitative analysis |
| 03/21/2006 | US7014839 Light imaging contrast agents |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/21/2006 | US7014610 Echogenic devices and methods of making and using such devices |
| 03/21/2006 | CA2154080C Novel anticoagulant cofactor activity |
| 03/16/2006 | WO2006028380A1 Mri method for imaging of the heart |
| 03/16/2006 | WO2006028129A1 Medicinal preparation |
| 03/16/2006 | WO2006027738A1 Compounds and methods for combined optical-ultrasound imaging |
| 03/16/2006 | WO2006027244A2 Paramagnetic metal polyamino complexes for mri visualization of internalized polynucleotides |
| 03/16/2006 | WO2006012639A9 Method of diagnosing, monitoring and treating pulmonary diseases |
| 03/16/2006 | WO2005084361A3 Multi-component biological transport systems |
| 03/16/2006 | US20060058642 Method for acquiring electromagnetic signals and contrast product therefor |
| 03/16/2006 | US20060058513 Oxime conjugates and methods for their formation and use |
| 03/16/2006 | US20060057147 Antibody recognizing antibody |
| 03/16/2006 | US20060057072 Method for diagnosis and treatment of vascular disease |
| 03/16/2006 | US20060057071 Paramagnetic complexes with pendant crown compounds showing improved targeting-specificity as MRI contrast agents |
| 03/16/2006 | US20060057070 Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use |
| 03/16/2006 | US20060057069 Detection of protein expression in vivo using fluorescent puromycin conjugates |
| 03/16/2006 | US20060057068 CA IX-specific inhibitors |
| 03/16/2006 | US20060057067 inhibiting cerebrospinal fluid (CSF) production; repeatedly removing CSF from subarachnoid space and replacing CSF by infusing a lymph-like fluid composition into space; neuro-cardiopulmonary resuscitation; artificial CSF is polypeptides (gelatins), ionic magnesium (Mg2+), ATP, and insulin; mild acidosis |
| 03/16/2006 | US20060057066 Reagent sets and gene signatures for renal tubule injury |
| 03/16/2006 | US20060057065 Composition and method to prevent and treat brain and spinal cord injuries |
| 03/16/2006 | US20060057064 Useful in SPECT image diagnosis, PET image diagnosis, MRI image diagnosis and the like, for imaging sites of inflammation |
| 03/16/2006 | US20060057063 Therapy of cancer, diagnosis, imaging; drug conjugate; targeting agent and an anti-cancer agent, wherein targeting agent comprises an erythropoietin receptor ligand |
| 03/16/2006 | DE102004038134A1 New multivalent chelator compounds containing a carbohydrate scaffold structure linked to chelator groups and coupling groups useful for modification and/or immobilization of target molecules e.g. proteins that carry an affinity-tag |
| 03/15/2006 | WO2007030124A2 Treatment screening methods |
| 03/15/2006 | EP1633773A2 D-amino acid peptides |
| 03/15/2006 | EP1633327A1 Method for improving stability and shelf-life of liposome complexes |
| 03/15/2006 | EP1590004A4 Improved thickened beverages for dysphagia |
| 03/15/2006 | EP1435908A4 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof |
| 03/15/2006 | EP1372648B1 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 03/15/2006 | EP1251875B1 Use of contrast agents in the manufacture of diagnostic agents for the visualisation of the intestinal lumen |
| 03/15/2006 | EP1007628B1 Transgenic model for heart failure |
| 03/15/2006 | CN1746187A Atrial fibrillation peccant gene and use thereof |
| 03/15/2006 | CN1746186A Atrial fibrillation peccant gene and use thereof |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/15/2006 | CN1245156C Methods for in vivo delivery of biologics and compositions therefor |
| 03/15/2006 | CA2590404A1 Treatment screening methods |
| 03/14/2006 | US7011817 Hydrophilic cyanine dyes |
| 03/14/2006 | US7011816 Complex of gallium-68 with a macrocyclic chelating agent linked via peptidyl spacer to one or more recognition units recognized by a multispecific targeting antibody |
| 03/14/2006 | US7011815 Magnetic resonance imaging; gadofosveset |
| 03/14/2006 | US7011814 Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject |
| 03/14/2006 | CA2407795C Fluorescein isothiocyanate (fitc) sinistrin, its production and use |
| 03/14/2006 | CA2375430C C-pyrazole a2a receptor agonists |
| 03/14/2006 | CA2250731C In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue |
| 03/09/2006 | WO2006026748A1 Method of manufacturing an auto-calibrating sensor |
| 03/09/2006 | WO2006026741A1 Wearable sensor device and system |
| 03/09/2006 | WO2006026348A1 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
| 03/09/2006 | US20060051358 Immune response assessment method |
| 03/09/2006 | US20060051314 Drug for prevention and/or treatment of constipation and sympton caused by constipation |
| 03/09/2006 | US20060051297 Ultrasound contrast agents and process for the preparation thereof |
| 03/09/2006 | US20060051296 Thickened beverages for dysphagia |
| 03/09/2006 | US20060051295 Estrogen receptor interaction with a transcription factor |
| 03/09/2006 | US20060051294 Method of predicting a diet effect |
| 03/09/2006 | DE10040380B4 MRI contrast agent for visualization of plaque, lymph nodes, infarcted and necrotic tissue or both necrosis and tumors, comprising perfluoroalkylated metal complex having specific micelle forming properties |
| 03/09/2006 | CA2797666A1 Peptide derivatives of exendin-3 |
| 03/09/2006 | CA2578030A1 Luminescent metal complexes for monitoring renal function |
| 03/08/2006 | EP1631561A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid |
| 03/08/2006 | EP1631318A2 Magnetic nanoparticles linked to a ligand |